Providing solutions for professionals working in reproductive medicine
Chief Operating Officer USA
Following 20+ years in both laboratory and clinical management in the IVF field, Dr. Gary Harton began his commercial career performing business development roles with two companies prominent in reproductive genetics. He has been involved in a number of exciting breakthroughs in the field of reproductive genetics including the first clinical PGD test for an autosomal dominant disease (Marfan syndrome), the first PGD case for spinal muscular atrophy (SMA), and the introduction of non-disclosing preimplantation genetic testing for Huntington disease. In addition, Dr. Harton has served on a number of international committees including the ESHRE PGD Consortium as well as the Steering Committee for External Quality Assessment through UK NEQAS.
Dr. Harton graduated from James Madison University in Harrisonburg, VA and completed his PhD work at the University of Kent, Canterbury, UK in Professor Darren Griffin’s department. He has numerous peer reviewed articles, abstracts and book chapters, and is certified by the American Board of Bioanalysis (ABB), is a member of American Society for Reproductive Medicine (ASRM), the European Society of Human Reproduction and Embryology (ESHRE), Preimplantation Genetic Diagnosis International Society and is an Honorary Senior Lecturer at the University of Kent. Dr. Harton has been an invited speaker all over the world and is frequently invited to lecture/teach students and professionals alike.
Business Development Director USA
Victor graduated in Industrial Engineering at the Polytechnic University of Valencia and earned a postgraduate degree in Business Administration at IESE and in Marketing at IE Business School in Madrid.
With more than 15 years of professional experience in the FMCG, he started working in a multinational company of consumer goods where he went on to become a national leader in the operations department where he became COO. His next professional leap was to Managing Director and later he submitted a draft purchase and invested with a venture capital firm where he developed general management functions focusing on international markets.
Currently he is part of the IGENOMIX team developing business strategies within the US as it is becoming the fastest growing company in its sector in this market.
Co-Founder & Executive Laboratory Director USA and Canada
Dr. Cengiz Cinnioglu is a Co-Founder and Laboratory Director of BlastoGen. He earned his PhD from Istanbul University, Turkey, in Forensic Science & Genetics. Dr. Cinnioglu began his career at the Hemogenetic department for Paternity Testing at Istanbul University Institute of Legal Medicine at Forensic Science & Genetics. He earned his undergraduate degree in Molecular Biology and Genetics.
Dr. Cinnioglu joined a pioneer research group led by Dr. Luca-Cavalli Sforza, who is a world-renowned geneticist, in tracking the genetic history of mankind at Stanford University in the Human Population Genetics Laboratory, as a collaborator for his PhD project. After completing his PhD, he continued to work in the same department as a post-doctoral fellow. His post doctoral research involves the molecular analysis of human DNA sequence variation in human populations and SNP’s discoveries on Y chromosomes.
After post doctorate fellowship he transitioned to Genetic Diagnosis on early human Embryo development with Fluorescence in situ hybridization (FISH) technique.
Dr. Cinnioglu joined Natera (Gene Security Network) in early 2007 to develop the first application in the world with new cutting edge microarray technology to screen all chromosomes on early human embryos. He has co-authored numerous patent applications during his research.
Dr. Cinnioglu has numerous peer-reviewed publications in respected scientific journals including Nature, American Journal Human Genetic, Human Genetics, Fertility and Sterility. He has presented at many national and international conferences.
Dr. Cinnioglu has a Laboratory Director License for Genetic Testing (Microarray for PGD), Cytogenetics, Andrology and Parentage/Identity testing from the New York State Department of Health. He is member of the American Society for Reproductive Medicine, The American Association of Bioanalysts and The Pre-implantation Genetic Diagnosis International Society.
Laboratory Manager Miami
Adedoyin Akinwole earned his Bachelor’s degree in Biology and Master’s degree in Public Health from the University of Miami, Miami Florida.
Adedoyin has over 4 years of clinic laboratory experience with IGENOMIX and is pursuing his Ph.D. in Genetics with focus on population genetics and aneuploidy.
Laboratory Manager New York
Milena Jakubowska grew up in Opole, Poland and graduated from Wroclaw University of Environmental and Life Sciences in 2011 with a Master’s degree in biotechnology. She also spent few months studying biotechnology at Universitat de Vic, Spain during her last semester at university.
After graduation, Milena moved to Birmingham, United Kingdom, where for four years she worked at specialist protein company - The Binding Site, initially as a lab technician and later on as a project scientist.
In September 2015 Milena moved to New York City and soon after joined Igenomix team at the Jersey City location. She started off as a lab technician, later being promoted to lab supervisor and eventually becoming the lab manager.
Laboratory Manager Los Angeles
Dr. Kayali received his Bachelor’s degree in Molecular Biology and Genetics and his Ph.D. in Biochemistry at Istanbul University, Cerrahpasa School of Medicine, Istanbul, Turkey.
Dr. Kayali has over 20 years of clinical and research laboratory experience, including supervising a clinical lab at Cerrahpasa School of Medicine, Istanbul, Turkey. Dr. Kayali also spent 4 years as a post-doctoral scholar, at the UCLA School of Medicine, working on finding a cure for Duchenne Muscular Dystrophy. This form of Muscular Dystrophy is caused by a mutation in the dystrophin gene, located on the human X chromosome. The main focus of his research was to develop both gene therapy strategies and small molecule compounds to restore dystrophin expression due to nonsense mutation for muscular dystrophies.
Dr. Kayali has over 30 peer-reviewed publications.
Alyssa Snider, MS, PhD, LCGC is a certified genetic counselor specializing in fertility genetic counseling, human genetics, and genetic research. She provides comprehensive genetic counseling for patients undergoing PGS and PGD and other tests offered by IGENOMIX. She serves as an educational resource for patients and clinicians alike.
Dr. Snider has taught graduate-level Human Genetics at the University of California, San Francisco. Dr. Snider has a long-standing interest in providing genetic counseling services to patients who struggle with infertility. She has conducted research that focused on understanding patient opinions on IVF treatment strategies, in particular, on twin pregnancies and the goal of reducing pregnancy-associated health risks by the use of elective transfer of a single embryo. In addition, she has investigated epigenetic and DNA repair mechanisms in the early preimplantation embryo.
Dr. Snider received her Ph.D. in Genetics at Stanford University and her M.S. in Genetic Counseling from California State University, Stanislaus. She holds a B.S. in Cellular/Molecular Biology and a B.A. in Chemistry from Fresno State University. Dr. Snider is a member of the American Society of Reproductive Medicine and the National Society of Genetic Counselors. She is certified with the American Board of Genetic Counseling.
Paulina Nassab, MS, LCGC is a certified genetic counselor specializing in fertility and prenatal genetic counseling.
She provides comprehensive genetic counseling for patients undergoing genetic testing offered by IGENOMIX, including PGS and PGD. She also serves as an educational resource for patients and clinicians.
Paulina had extensive experience providing clinical genetic counseling at an academic medical center prior to joining IGENOMIX. Her experience included counseling patients undergoing fertility treatment on the benefits and limitations of expanded carrier screening and PGS, as well as counseling patients in a high-risk maternal-fetal-medicine office. Paulina received her M.S. in Genetic Counseling from California State University, Stanislaus. She is a member of the American Society of Reproductive Medicine (ASRM) and the National Society of Genetic Counselors (NSGC). Paulina is certified with the American Board of Genetic Counseling.
She received her B.A. from Brown University, and her M.S. in Genetic Counseling from Johns Hopkins University.
She is board certified in Genetic Counseling by the American Board of Genetic Counselors (ABGC) and has licensure in 10 states.
Jamie provides counseling for couples with a range of fertility problems, concerns about medical or family history, and advanced maternal age.
She is an active member of the National Society of Genetic Counselors (NSGC) and the American Society for Reproductive Medicine (ASRM).
She trained at the University of British Columbia in Canada and has been involved in research exploring pregnancy outcomes associated with maternal age, mosaicism, and has also worked with families struggling with infertility.
Counselling families on aneuploidy in pregnancy has been a focus of her work both in fertility clinics and in the BC Provincial Department of Medical Genetics. She was part of a small team of genetic counselors, medical geneticists and scientists given the task of re-creating the BC Provincial Prenatal Screening Program. She has also been involved with the Down Syndrome Society of Canada and is an active member of the Canadian Association of Genetic Counsellors and the National Society of Genetic Counselors. She is certified to practice both in the United States and Canada.
She obtained her undergraduate degree at the University of Victoria in genetics. With a passion for helping families before during and after pregnancy Monica has also trained as a lactation counselor and a birth doula.